Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07009795 · ClinicalTrials.gov registry record · NA

Rise & Renew: Supporting Well-Being in Black Women After the Loss of a Loved One

A NA study of Psychological Distress and Grief, sponsored by Lillian Haley, PhD.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07009795: Active NA study of Psychological Distress and Grief, sponsored by Lillian Haley, PhD.

NCT07009795 is a NA study of Psychological Distress and Grief that is active but no longer recruiting, run by Lillian Haley, PhD. The registered enrollment target is 40 participants, below the 471-participant average among 28 other Psychological Distress trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07009795, a NA study of Psychological Distress and Grief, is active but no longer recruiting, sponsored by Lillian Haley, PhD.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is testing a new grief support program called Rise \& Renew (Remembering, Expressing, Navigating, Embracing, Witnessing) designed for Black women ages 40 and older who have experienced the loss of a close loved one, such as a spouse or significant other, parent, or child (including pregnancies). The program includes a weekend wellness retreat followed by 10 weeks of online group support. Participants will be randomly assigned to start weekly virtual sessions right away or after a 10-week delay. The study will help the investigators learn whether the program is helpful, easy to take part in, and meaningful for those who attend. The investigators believe that a culturally tailored program that focuses on healing, wellness, and community will improve emotional health, spiritual well-being, and resilience during the grief process.

Primary Outcome

The 4-item Feasibility of Intervention Measure was developed for evaluating the success of feasibility, demonstrating encouraging psychometric properties. The items that are scored on a scale of 0 to 4, where 0 indicates "completely disagree," and 4 indicates "completely agree". Thus, the range for each scale extends from 0 - 16, with higher scores indicating higher feasibility.

Interventions

  • BEHAVIORAL Rise & Renew Hybrid Grief Support Program

Study Locations (1)

Georgia

  • Serenity Haven - Lithonia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-05-20
Est. Completion 2026-05-19
Phase NA
Lillian Haley, PhD

1 total trials

What the registry record for NCT07009795 still lists

NCT07009795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 471-participant average among 28 other Psychological Distress trials with a reported enrollment target (92% lower).

The record links to 4 conditions, with Psychological Distress appearing as the primary indexed condition, and to 1 intervention - of which Rise & Renew Hybrid Grief Support Program is the first listed.

NCT07009795 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT07009795 about?

NCT07009795 is a clinical study titled "Rise & Renew: Supporting Well-Being in Black Women After the Loss of a Loved One". This study is testing a new grief support program called Rise \& Renew (Remembering, Expressing, Navigating, Embracing, Witnessing) designed for Black women ages 40 and older who have experienced the loss of a close loved one, such as a spouse or significant other, parent, or child (including pregna...

What is the current status of trial NCT07009795?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-05-20. Estimated completion is 2026-05-19.

What conditions does trial NCT07009795 study?

This clinical trial studies the following conditions: Psychological Distress, Grief, Well-being, Bereavement.

What interventions are being tested in trial NCT07009795?

The interventions under investigation include: Rise & Renew Hybrid Grief Support Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07009795?

This trial is sponsored by Lillian Haley, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07009795 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychological Distress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07009795's enrollment target sits among peer trials

40 20th of 28 higher than 7 of 28 other Psychological Distress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychological Distress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07009795, the US trial registry maintained by the National Library of Medicine. NCT07009795 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.